Analysis of problems in implementing the National catalog of medicinal products prices into the system of pharmaceutical provision of the population of Ukraine

Анотація

Regulation of drug prices is considered an important tool in shaping the country's national pharmaceutical security. In early 2025, Ukraine introduced a number of regulatory innovations aimed at increasing the availability of drugs for the population. One of the directions of this process was the introduction of price referencing/declaration mechanisms and the introduction of the National Drug Price Catalog. The aim – to analyze the problems of implementing the National Price Catalog for Medicines into the system of pharmaceutical provision for the population in Ukraine. Data from official websites of state institutions operating in healthcare, professional mass media sources, as well as scientific publications on the specified topic were used. The research used theoretical research methods (historical, logical, critical approach of interpretative synthesis, etc.) The article analyzes the regulatory framework that is the basis for the effective implementation of the National Catalog of Drug Prices and the regulation of their availability in the healthcare system. A new definition of the «Regulatory group of drugs» is presented, which allows analyzing the impact of the relevant mechanisms on the availability of drugs. An analysis of the current version of the National Drug Price Catalog was conducted. It was proven that the introduction of referencing/declaration of drug prices should correspond to the levels of medical and pharmaceutical care provided to the population and not lead to excessive regulatory influence on the circulation of drugs. The main characteristics and problems of the implementation of the National Catalog of Drug Prices in Ukraine are identified and the directions for their solution are outlined. The introduction of mechanisms for summarizing and declaring prices on the pharmaceutical market in the absence of a preliminary study of the relevant risks, an assessment methodology and a system of indicators of the effectiveness of their implementation, and coordination of the opinions of various business entities may have unpredictable consequences for the sustainable development of the domestic healthcare system. Therefore, it is necessary to conduct a systematic analysis of the consequences of the introduction of the National Price Catalog into the domestic healthcare system and develop directions for further promotion of regulatory mechanisms in practical pharmacy.

Класифікація

Ідентифікатори

Схожі роботи